| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736484 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SQSTM1 mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:736485 | 6480464 | Ethinyl Estradiol results in decreased expression of SQSTM1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of SQSTM1 mRNA | CTD | PMID:17108234 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736485 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SQSTM1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736485 | 6480464 | Ethinyl Estradiol results in increased expression of SQSTM1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | ISO | RGD:736484 | 6480464 | Estradiol results in decreased expression of SQSTM1 mRNA | CTD | PMID:16474171 |
| 17beta-estradiol | increases expression | ISO | RGD:736484 | 6480464 | Estradiol results in increased expression of SQSTM1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736485 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SQSTM1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736485 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SQSTM1 mRNA | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736485 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SQSTM1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SQSTM1 mRNA | CTD | PMID:22298810 |
| 2-butoxyethanol | increases expression | ISO | RGD:736485 | 6480464 | n-butoxyethanol results in increased expression of SQSTM1 mRNA | CTD | PMID:19812364 |
| 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of SQSTM1 mRNA | CTD | PMID:9681501 |
| 3-methyladenine | increases expression | ISO | RGD:736484 | 6480464 | 3-methyladenine results in increased expression of SQSTM1 protein | CTD | PMID:20574048 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of SQSTM1 mRNA | CTD | PMID:19162173 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:736485 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA | CTD | PMID:19191707 |
| acarbose | affects response to substance | ISO | RGD:736485 | 6480464 | SQSTM1 affects the susceptibility to Acarbose | CTD | PMID:19207582 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:736484 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of SQSTM1 mRNA | CTD | PMID:15894607 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736484 | 6480464 | Tretinoin results in increased expression of SQSTM1 mRNA | CTD | PMID:15894607 |
| amiodarone | increases expression | ISO | RGD:736484 | 6480464 | Amiodarone results in increased expression of SQSTM1 mRNA | CTD | PMID:19774075 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SQSTM1 mRNA | CTD | PMID:16483693 |
| antimycin A | increases expression | ISO | RGD:736485 | 6480464 | Antimycin A results in increased expression of SQSTM1 mRNA | CTD | PMID:19304788 |
| arachidonic acid | increases expression | ISO | RGD:736484 | 6480464 | Arachidonic Acid results in increased expression of SQSTM1 mRNA | CTD | PMID:16704987 |
| arsenite(3-) | increases expression | ISO | RGD:736485 | 6480464 | arsenite results in increased expression of SQSTM1 mRNA | CTD | PMID:15894712 |
| arsenite(3-) | multiple interactions | ISO | RGD:736485 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of SQSTM1 mRNA | CTD | PMID:15894712 |
| astemizole | increases expression | EXP | | 6480464 | Astemizole results in increased expression of SQSTM1 mRNA | CTD | PMID:20221588 |
| benzo[a]pyrene | increases expression | ISO | RGD:736484 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:736485 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:15034205 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736485 | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of SQSTM1 mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | increases expression | ISO | RGD:736484 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:736484 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:736485 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:21569818 PMID:15894712 |
| benzo[a]pyrene | increases expression | ISO | RGD:736485 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:15894712 PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736485 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of SQSTM1 mRNA | CTD | PMID:15894712 |
| benzo[a]pyrene | increases expression | ISO | RGD:736485 | 6480464 | Benzo(a)pyrene results in increased expression of SQSTM1 mRNA | CTD | PMID:15894712 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736485 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SQSTM1 mRNA | CTD | PMID:21715664 |
| bicalutamide | increases expression | ISO | RGD:736484 | 6480464 | bicalutamide results in increased expression of SQSTM1 mRNA | CTD | PMID:15638997 |
| bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | RGD:736484 | 6480464 | Mustard Gas results in increased phosphorylation of SQSTM1 protein | CTD | PMID:19845377 |
| bisphenol A | decreases expression | ISO | RGD:736484 | 6480464 | bisphenol A results in decreased expression of SQSTM1 mRNA | CTD | PMID:16474171 |
| bisphenol A | increases expression | ISO | RGD:736485 | 6480464 | bisphenol A results in increased expression of SQSTM1 mRNA | CTD | PMID:12233820 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:22110744 |
| cadmium dichloride | increases expression | ISO | RGD:736485 | 6480464 | Cadmium Chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:11958953 PMID:15501611 |
| cadmium dichloride | multiple interactions | ISO | RGD:736485 | 6480464 | MT1 affects the reaction [Cadmium Chloride results in increased expression of SQSTM1 mRNA]; more ... | CTD | PMID:11958953 |
| cadmium dichloride | increases expression | ISO | RGD:736485 | 6480464 | Cadmium Chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:15501611 PMID:11958953 |
| caffeine | increases expression | EXP | | 6480464 | Caffeine results in increased expression of SQSTM1 mRNA | CTD | PMID:20864626 |
| caffeine | decreases expression | ISO | RGD:736484 | 6480464 | Caffeine results in decreased expression of SQSTM1 protein | CTD | PMID:21081844 |
| calcium atom | affects expression | EXP | | 6480464 | Calcium affects the expression of SQSTM1 mRNA | CTD | PMID:15913539 |
| calcium(0) | affects expression | EXP | | 6480464 | Calcium affects the expression of SQSTM1 mRNA | CTD | PMID:15913539 |
| celecoxib | multiple interactions | ISO | RGD:736484 | 6480464 | [celecoxib co-treated with ABT-737] results in decreased expression of SQSTM1 protein | CTD | PMID:20104024 |
| ciglitazone | multiple interactions | ISO | RGD:736484 | 6480464 | [ciglitazone binds to PPARG protein] which results in increased expression of SQSTM1 mRNA | CTD | PMID:16197558 |
| ciprofibrate | increases expression | ISO | RGD:736485 | 6480464 | ciprofibrate results in increased expression of SQSTM1 mRNA | CTD | PMID:12771043 |
| cisplatin | multiple interactions | ISO | RGD:736484 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SQSTM1 mRNA] | CTD | PMID:21858171 |
| cisplatin | decreases response to substance | ISO | RGD:736484 | 6480464 | SQSTM1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:21371883 |
| cisplatin | increases expression | ISO | RGD:736484 | 6480464 | Cisplatin results in increased expression of SQSTM1 protein | CTD | PMID:21184746 |
| clofibrate | multiple interactions | ISO | RGD:736485 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SQSTM1 mRNA; more ... | CTD | PMID:17585979 |
| cobalt atom | multiple interactions | ISO | RGD:736484 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of SQSTM1 mRNA | CTD | PMID:18078969 |
| cobalt dichloride | increases expression | ISO | RGD:736484 | 6480464 | cobaltous chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:736484 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SQSTM1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:736484 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SQSTM1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:736484 | 6480464 | Copper Sulfate results in increased expression of SQSTM1 mRNA | CTD | PMID:19549813 |
| copper(II) chloride | increases expression | ISO | RGD:736484 | 6480464 | cupric chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:17211630 |
| coumestrol | multiple interactions | ISO | RGD:736484 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA | CTD | PMID:19167446 |
| coumestrol | decreases expression | ISO | RGD:736484 | 6480464 | Coumestrol results in decreased expression of SQSTM1 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | affects expression | ISO | RGD:736484 | 6480464 | Asbestos, Crocidolite affects the expression of SQSTM1 mRNA | CTD | PMID:17331233 |
| crocidolite asbestos | increases expression | ISO | RGD:736484 | 6480464 | Asbestos, Crocidolite results in increased expression of SQSTM1 mRNA | CTD | PMID:18687144 |
| cyclosporin A | increases expression | ISO | RGD:736484 | 6480464 | Cyclosporine results in increased expression of SQSTM1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:736485 | 6480464 | Cyclosporine results in increased expression of SQSTM1 mRNA | CTD | PMID:19770486 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:736485 | 6480464 | Tetrahydrocannabinol results in increased expression of SQSTM1 mRNA | CTD | PMID:21542829 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:736484 | 6480464 | Tetrahydrocannabinol results in increased expression of SQSTM1 mRNA | CTD | PMID:16597638 |
| diarsenic trioxide | increases expression | ISO | RGD:736484 | 6480464 | arsenic trioxide results in increased expression of SQSTM1 protein | CTD | PMID:20200477 |
| diarsenic trioxide | multiple interactions | ISO | RGD:736484 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of SQSTM1 mRNA | CTD | PMID:15894607 |
| diarsenic trioxide | increases expression | ISO | RGD:736484 | 6480464 | arsenic trioxide results in increased expression of SQSTM1 protein | CTD | PMID:20200477 PMID:21594580 |
| diarsenic trioxide | decreases response to substance | ISO | RGD:736484 | 6480464 | SQSTM1 protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| diazoxide | increases expression | ISO | RGD:736485 | 6480464 | Isoproterenol results in increased expression of SQSTM1 mRNA | CTD | PMID:20003209 |
| dibenzofuran | decreases expression | ISO | RGD:736484 | 6480464 | dibenzofuran results in decreased expression of SQSTM1 protein | CTD | PMID:22173198 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of SQSTM1 mRNA | CTD | PMID:21551480 |
| doxorubicin | increases expression | ISO | RGD:736484 | 6480464 | Doxorubicin results in increased expression of SQSTM1 protein | CTD | PMID:21184746 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of SQSTM1 mRNA | CTD | PMID:19915844 |
| doxorubicin | increases expression | ISO | RGD:736485 | 6480464 | Doxorubicin results in increased expression of SQSTM1 mRNA | CTD | PMID:16243910 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of SQSTM1 mRNA | CTD | PMID:16098508 |
| ethanol | decreases expression | ISO | RGD:736485 | 6480464 | Ethanol results in decreased expression of SQSTM1 protein | CTD | PMID:22459179 |
| ethanol | multiple interactions | ISO | RGD:736485 | 6480464 | [wortmannin co-treated with Ethanol] results in increased expression of SQSTM1 protein | CTD | PMID:22459179 |
| fluoxetine | decreases expression | ISO | RGD:736485 | 6480464 | Fluoxetine results in decreased expression of SQSTM1 mRNA | CTD | PMID:17105902 |
| formaldehyde | increases expression | ISO | RGD:736484 | 6480464 | Formaldehyde results in increased expression of SQSTM1 mRNA | CTD | PMID:20655997 |
| fumonisin B1 | increases expression | ISO | RGD:736485 | 6480464 | fumonisin B1 results in increased expression of SQSTM1 mRNA | CTD | PMID:16221962 |
| genistein | decreases expression | ISO | RGD:736484 | 6480464 | Genistein results in decreased expression of SQSTM1 mRNA | CTD | PMID:16474171 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:736484 | 6480464 | SQSTM1 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:17360324 |
| hypochlorous acid | increases expression | ISO | RGD:736485 | 6480464 | Hypochlorous Acid results in increased expression of SQSTM1 mRNA | CTD | PMID:19376150 |
| imatinib | increases expression | EXP | | 6480464 | imatinib results in increased expression of SQSTM1 protein | CTD | PMID:22641616 |
| isoprenaline | increases expression | ISO | RGD:736485 | 6480464 | Isoproterenol results in increased expression of SQSTM1 mRNA | CTD | PMID:20003209 |
| LY294002 | multiple interactions | ISO | RGD:736484 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] | CTD | PMID:17360324 |
| methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:20864626 |
| methylmercury(1+) | increases expression | EXP | | 6480464 | methylmercury II results in increased expression of SQSTM1 mRNA | CTD | PMID:17905399 |
| N-methylformamide | affects expression | ISO | RGD:736485 | 6480464 | methylformamide analog affects the expression of SQSTM1 mRNA; more ... | CTD | PMID:17040096 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:736485 | 6480464 | Diethylnitrosamine results in increased expression of SQSTM1 mRNA | CTD | PMID:12771043 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of SQSTM1 mRNA | CTD | PMID:22110744 |
| paracetamol | increases expression | ISO | RGD:736485 | 6480464 | Acetaminophen results in increased expression of SQSTM1 mRNA | CTD | PMID:11264010 PMID:12540782 |
| paracetamol | increases expression | ISO | RGD:736484 | 6480464 | Acetaminophen results in increased expression of SQSTM1 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:736485 | 6480464 | Acetaminophen affects the expression of SQSTM1 mRNA | CTD | PMID:17562736 PMID:15606129 |
| paracetamol | multiple interactions | ISO | RGD:736485 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of SQSTM1 mRNA] | CTD | PMID:12540782 |
| paracetamol | affects expression | ISO | RGD:736485 | 6480464 | Acetaminophen affects the expression of SQSTM1 mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:736485 | 6480464 | Acetaminophen results in increased expression of SQSTM1 mRNA | CTD | PMID:12540782 PMID:11264010 |
| paracetamol | multiple interactions | ISO | RGD:736485 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SQSTM1 mRNA; more ... | CTD | PMID:17585979 |
| paraquat | increases degradation | ISO | RGD:736484 | 6480464 | Paraquat results in increased degradation of SQSTM1 protein | CTD | PMID:20929985 |
| paraquat | increases expression | ISO | RGD:736485 | 6480464 | Paraquat results in increased expression of SQSTM1 mRNA | CTD | PMID:12595580 |
| paraquat | multiple interactions | ISO | RGD:736484 | 6480464 | [Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein; more ... | CTD | PMID:20929985 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SQSTM1 mRNA | CTD | PMID:18692542 |
| phenobarbital | multiple interactions | ISO | RGD:736485 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SQSTM1 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:736485 | 6480464 | Phenobarbital affects the expression of SQSTM1 mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:736485 | 6480464 | Phenobarbital results in increased expression of SQSTM1 mRNA | CTD | PMID:19482888 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of SQSTM1 mRNA | CTD | PMID:18158353 |
| pirinixic acid | multiple interactions | ISO | RGD:736484 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SQSTM1 mRNA | CTD | PMID:19710929 |
| piroxicam | multiple interactions | ISO | RGD:736484 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SQSTM1 mRNA] | CTD | PMID:21858171 |
| piroxicam | decreases expression | ISO | RGD:736484 | 6480464 | Piroxicam results in decreased expression of SQSTM1 mRNA | CTD | PMID:21858171 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of SQSTM1 mRNA | CTD | PMID:19162173 |
| progesterone | increases expression | ISO | RGD:736484 | 6480464 | Progesterone results in increased expression of SQSTM1 mRNA | CTD | PMID:18037150 |
| quercetin | increases expression | ISO | RGD:736484 | 6480464 | Quercetin results in increased expression of SQSTM1 mRNA | CTD | PMID:21632981 |
| raloxifene | increases expression | EXP | | 6480464 | Raloxifene results in increased expression of SQSTM1 mRNA | CTD | PMID:15576828 |
| retinyl acetate | increases expression | ISO | RGD:736485 | 6480464 | retinol acetate results in increased expression of SQSTM1 mRNA | CTD | PMID:16772331 |
| Ro 31-8220 | multiple interactions | ISO | RGD:736484 | 6480464 | Ro 31-8220 inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] | CTD | PMID:17360324 |
| rotenone | decreases response to substance | ISO | RGD:736484 | 6480464 | SQSTM1 protein results in decreased susceptibility to Rotenone | CTD | PMID:17360324 |
| rotenone | increases expression | ISO | RGD:736485 | 6480464 | Rotenone results in increased expression of SQSTM1 mRNA | CTD | PMID:19304788 |
| silicon dioxide | increases expression | ISO | RGD:736485 | 6480464 | Silicon Dioxide results in increased expression of SQSTM1 mRNA | CTD | PMID:19073995 |
| sirolimus | decreases expression | ISO | RGD:736484 | 6480464 | Sirolimus results in decreased expression of SQSTM1 protein | CTD | PMID:19773376 |
| sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of SQSTM1 mRNA | CTD | PMID:22110744 |
| sodium dichromate | decreases expression | ISO | RGD:736485 | 6480464 | sodium bichromate results in decreased expression of SQSTM1 mRNA | CTD | PMID:22155349 |
| sodium dichromate | increases expression | ISO | RGD:736485 | 6480464 | sodium bichromate results in increased expression of SQSTM1 mRNA | CTD | PMID:22155349 |
| succimer | multiple interactions | ISO | RGD:736485 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQSTM1 mRNA | CTD | PMID:21641980 |
| sulindac | increases expression | ISO | RGD:736484 | 6480464 | Sulindac results in increased expression of SQSTM1 mRNA | CTD | PMID:11906190 |
| tamoxifen | affects expression | ISO | RGD:736485 | 6480464 | Tamoxifen affects the expression of SQSTM1 mRNA | CTD | PMID:17555576 |
| testosterone enanthate | affects expression | ISO | RGD:736484 | 6480464 | testosterone enanthate affects the expression of SQSTM1 mRNA | CTD | PMID:17440010 |
| trichloroethene | multiple interactions | ISO | RGD:736485 | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of SQSTM1 mRNA] | CTD | PMID:15363585 |
| troglitazone | increases expression | ISO | RGD:736484 | 6480464 | troglitazone results in increased expression of SQSTM1 mRNA | CTD | PMID:19140230 |
| valproic acid | affects expression | ISO | RGD:736485 | 6480464 | Valproic Acid affects the expression of SQSTM1 mRNA | CTD | PMID:17292431 |
| wortmannin | multiple interactions | ISO | RGD:736485 | 6480464 | [wortmannin co-treated with Ethanol] results in increased expression of SQSTM1 protein | CTD | PMID:22459179 |
| wortmannin | increases expression | ISO | RGD:736485 | 6480464 | wortmannin results in increased expression of SQSTM1 protein | CTD | PMID:22459179 |
| wortmannin | decreases expression | ISO | RGD:736485 | 6480464 | wortmannin results in decreased expression of SQSTM1 protein | CTD | PMID:22459179 |
| zinc atom | multiple interactions | ISO | RGD:736484 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SQSTM1 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:736484 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SQSTM1 mRNA | CTD | PMID:18593933 |